
GMAB
Genmab A/S
$28.60
+$0.32(+1.13%)
59
Overall
60
Value
58
Tech
--
Quality
Market Cap
$18.69B
Volume
744.90K
52W Range
$17.24 - $28.75
Target Price
$30.90
Order:
Income Statement
Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|
REVENUE | |||||
Total Revenue | $14.5B | $16.5B | $21.5B | ||
Total Revenue | $14.5B | $16.5B | $21.5B | ||
COST OF GOODS SOLD | |||||
Cost of Revenue | -- | $226.0M | $985.0M | ||
GROSS PROFIT | |||||
Gross Profit | $14.5B | $16.2B | $20.5B | ||
OPERATING EXPENSES | |||||
Operating Expenses | $8.2B | $10.9B | $13.8B | ||
Research & Development | $5.6B | $7.6B | $9.7B | ||
Research Expense | $5.6B | $7.6B | $9.7B | ||
Selling, General & Administrative | $2.7B | $3.3B | $3.8B | ||
Selling & Marketing Expenses | $2.7B | $3.3B | $3.8B | ||
OPERATING INCOME | |||||
Operating income | $6.3B | $5.3B | $6.7B | ||
EBITDA | $8.6B | $6.3B | $10.0B | ||
NON-OPERATING ITEMS | |||||
Interest Expense (Non-Operating) | $-21.0M | $344.0M | $383.0M | ||
Intinc | $324.0M | $1.5B | $1.5B | ||
Net Non-Operating Interest Income/Expense | $1.0B | $316.0M | $2.5B | ||
Gain on Sale of Securities | $-659.0M | -- | -- | ||
Other Income/Expense | $659.0M | $-596.0M | -- | ||
PRE-TAX INCOME | |||||
EBIT | $8.3B | $6.0B | $9.5B | ||
Pre-Tax Income | $8.3B | $5.6B | $9.2B | ||
INCOME TAX | |||||
Tax Provision | $1.5B | $1.3B | $1.3B | ||
NET INCOME | |||||
Net Income | $6.8B | $4.4B | $7.8B | ||
Net Income (Continuing Operations) | $6.8B | $4.4B | $7.8B | ||
Net Income (Discontinued Operations) | $6.8B | $4.4B | $7.8B | ||
Net Income (Common Stockholders) | $6.8B | $4.4B | $7.8B | ||
Normalized Income | $6.1B | $4.1B | $9.4B | ||
TOTALS | |||||
Total Expenses | $8.2B | $11.2B | $14.8B | ||
SHARE & EPS DATA | |||||
Average Shares Outstanding | $65.4M | $65.3M | -- | ||
Average Shares Outstanding (Diluted) | $66.0M | $65.9M | -- | ||
Shares Outstanding | $661.9M | $661.9M | $661.9M | ||
Basic EPS | $83.38 | $66.64 | -- | ||
Basic EPS (Continuing Operations) | $83.38 | $66.64 | -- | ||
Diluted EPS | $82.59 | $66.02 | -- | ||
Diluted EPS (Continuing Operations) | $82.59 | $66.02 | -- | ||
OTHER METRICS | |||||
Acquisition Expense | -- | -- | $300.0M | ||
Development Expense | $1.6B | -- | -- | ||
Other Costof Revenue | -- | $226.0M | $985.0M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | GMAB | $28.60 | +1.1% | 744.90K |
3 | ||||
4 | ||||
5 | ||||
6 |